UBS Rates Quantinuum (QNT) buy, $93 Price Target
UBS analyst David Vogt has kept a buy rating on Quantinuum Inc. QNT with a $93 price target, a 13.78% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
UBS rated Quantinuum Inc. ($QNT) "buy" with a $93 price target on June 29, 2026.
Since the rating, $QNT is up 14.2% after 1 week, down 35.0% after 1 month and down 49.8% to date (from the $72.84 close on Jun 29, 2026).
Key Points
- UBS analyst David Vogt reiterated a buy rating on Quantinuum Inc. QNT on June 29, 2026, setting a $93 price target.
- UBS's $93 price target implies 13.78% upside from Quantinuum Inc.'s ($QNT) current $81.74 share price.
- Quantinuum Inc. QNT shares trade at $81.74, closing in on the upper boundary of their 52-week range between $46.54 and $86.79.
- The broader analyst group maintains a strong buy recommendation key with a mean price target of $97.17 across 12 opinions.
Get $QNT trade alerts by text
We text you when insiders, Congress or big funds trade $QNT. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Quantinuum Inc. alert may contain errors. Disclosures
UBS Maintains Buy Rating on Quantinuum Inc.
UBS has kept a positive stance on Quantinuum Inc. QNT, as analyst David Vogt reaffirmed a buy rating on the technology firm on June 29, 2026. The firm kept its price target at $93 for the quantum computing developer. This update follows a busy stretch of reviews from major financial institutions covering the software company's growth potential.
UBS vs. the S&P 500
Hypothetical returns from UBS's disclosed trades, not real profit or advice. How we model this.
Stock Price Trades Near Upper Limits
Quantinuum Inc. QNT shares trade at $81.74, sitting close to the upper end of the company's 52-week range of $46.54 to $86.79. The equity remains well above both its 50-day moving average of $54.91 and its 200-day moving average of $59.15. With a market capitalization near $2.01 billion, the stock has drawn strong attention from Wall Street during its recent market run.
$QNT price target
Quantinuum Inc. daily closes and this analyst's $93 target. Not advice.
Recent Analyst Ratings and Coverage
Wall Street firms have kept a steady flow of updates on Quantinuum Inc. QNT over recent months. On June 29, 2026, Morgan Stanley initiated coverage with an equal-weight rating and a $78 price target, while TD Cowen also initiated coverage with a buy rating. Later in the summer, on August 12, 2026, Needham kept a buy rating and a $100 price target, Cantor Fitzgerald reiterated an overweight rating with a $90 target, and Bernstein kept an outperform rating with a $95 target. Rosenblatt also maintained a buy rating with a $155 target on August 12, 2026, and again on August 19, 2026. More recently, on October 15, 2026, Morgan Stanley updated its view, upgrading the stock to overweight with a $62 target. Across 12 total analyst opinions, the stock carries a strong buy recommendation key, backed by a mean price target of $97.17, a high target of $155.00, and a low target of $78.00.
Inside Quantinuum Inc.
Quantinuum Inc. builds quantum computing hardware and software, offering platforms, developer tools, application libraries, and middleware designed for real-world deployment. Based in Broomfield, Colorado and founded in 2021, the company employs about 800 people to advance quantum solutions for commercial markets.
Looking Ahead to Earnings and Updates
Investors will look toward the next earnings report scheduled for November 9, 2026, for further updates on the company's financial progress and software adoption rates. Market participants continue to watch how management executes its hardware and middleware strategy.
Source: UBS's rating change on $QNT (Jun 29, 2026). Written by software, not financial advice. How we make alerts